Clinical Trial Update: Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Abraxane in combination with carboplatin for small cell lung cancer. The study was terminated and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-06-12